Displaying items by tag:
Enhanced technologies at UAB’s Lister Hill Library allow education and research to be conducted in a virtual space by students, faculty and staff.
U.S. News & World Report ranking features a number of UAB programs ranked in the top 25, including a School of Health Professions’ master’s program at No. 1.
UAB’s new $25 million, 90-ton cyclotron has been installed in the UAB Proton Therapy Center.
11 players take part in graduation service on eve of UAB’s matchup with Northern Illinois in the Cheribundi Boca Raton Bowl.
When one family noticed a need for basic items in UAB Hospital, they decided to pay it forward to others.
Frequent, proper handwashing is critical to helping protect yourself and others you come in contact with during flu season.
Ingram was sick and no one knew the cause, until the right doctors on the right night saved his life.
El sitio web – www.uab.edu/flu – tiene información sobre la vacuna contra la influenza, recursos de prevención y tratamiento, y videos en español con preguntas comunes sobre la vacuna, síntomas y donde conseguir ayuda.
This week is about superlatives: The best health care. The newest athletic facilities. And a marketing campaign that explains our proudest achievements.
This week is all about progress: Opening of the new UAB Police headquarters, mixing personal medicine and politics and revealing the beauty of Collat's "Steps to Success."
This week, UAB is on the move. Teens tackle dangerous driving habits in a simulator, a new Blazer-themed locomotive takes to the tracks and preparations are underway for summer commencement Aug. 10-11.
This week is all about making strides. The UAB Kidney Chain passed 100 transplants. Students showcased their work in the summer EXPO. And football fans got a peek inside the upcoming season.
This week, high school students learn how to be cyber detectives, WBRC FOX6 pays it forward to an artist-in-residence on campus and two online degrees earn honors.
This week, a common blood pressure drug is revealed to be an effective therapy for Type I diabetes, a team from NSF is helping faculty and staff better understand how to commercialize their technology and work on the new intramural fields is nearly complete.